SCHEMBL19633220

SCHEMBL19633220

C=CCOC(=O)Nc1ccc(CNC(=O)c2cc(NC(=O)c3nc(N)cn3C)cn2C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERBB2 P04626 2/20 0.40
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC8 Q9BY41 2/20 0.36
▸ HRAS P01112 3/20 0.36
▸ ESR1 P03372 3/20 0.36
▸ ESR2 Q92731 3/20 0.36
▸ TOP1 P11387 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ USP4 Q13107 1/20 0.35
▸ USP7 Q93009 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TUBB4A P04350 1/20 0.34
▸ TUBB P07437 1/20 0.34
▸ TUBA3C P0DPH7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19636936 0.99 ERBB2 (0.40) ERBB2HDAC1HDAC2HDAC8HRAS
SCHEMBL19636845 0.86 ERBB2 (0.40) ERBB2HDAC1HDAC2HDAC8KDM4E
SCHEMBL19636934 0.85 ERBB2 (0.41) ERBB2HDAC1HDAC2HDAC8MAPT
SCHEMBL19633222 0.84 USP4 (0.39) KDM4EPOLBUSP4USP7ALDH1A1
SCHEMBL19633223 0.83 NAMPT (0.43) HDAC1HRASESR1ESR2TOP1
SCHEMBL19633090 0.80 ERBB2 (0.41) ERBB2HRASESR1ESR2AGPAT2
SCHEMBL19633039 0.80 ERBB2 (0.40) ERBB2HRASESR1ESR2KDM4E
SCHEMBL19637502 0.80 ERBB2 (0.42) ERBB2HDAC1HDAC2HDAC8HRAS
Hydrochloric Acid SCHEMBL30464359 0.80 ERBB2 (0.41) ERBB2HRASESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL30045834 0.80 MAPT (0.36) HRASESR1ESR2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof MERSANA THERAPEUTICS, INC. (US) 2020-05-26 — — US disclosed
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2019-03-07 — — US disclosed
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-11-23 — — US disclosed
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B ERBB2 65/4885HDAC1 1672/4885HDAC2 1196/4885
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B ERBB2 65/4885HDAC1 1672/4885HDAC2 1196/4885
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof CD79B, CLTB, FCGR3B ERBB2 65/4885HDAC1 1672/4885HDAC2 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback